PHO.OL
Photocure ASA News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 1,
"returned": 1,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "12a97ef4-ccac-45ad-95cd-b1c64be8e8e9",
"title": "Photocure ASA: Results for the first quarter of 2024 By Investing.com",
"description": "Photocure ASA: Results for the first quarter of 2024",
"keywords": "",
"snippet": "OSLO, Norway , May 15, 2024 /PRNewswire/ -- Photocure ASA (OSE:PHO) today reported Hexvix ®/Cysview ® revenues of NOK 116.8 million in the first quarter of 20...",
"url": "https://www.investing.com/news/press-releases/photocure-asa-results-for-the-first-quarter-of-2024-93CH-3441156",
"image_url": "https://i-invdn-com.investing.com/news/World_News_8_800x533_L_1420026210.jpg",
"language": "en",
"published_at": "2024-05-15T06:48:05.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "PHO.OL",
"name": "Photocure ASA",
"exchange": null,
"exchange_long": null,
"country": "no",
"type": "equity",
"industry": "Healthcare",
"match_score": 171.47223,
"sentiment_score": 0.134783,
"highlights": [
{
"highlight": "OSLO, Norway , May 15, 2024 /PRNewswire/ -- <em>Photocure</em> <em>ASA</em> (<em>OSE:PHO</em>) today reported Hexvix ®/Cysview ® revenues of NOK 116.8 million in the first quarter of 2024 (Q1 2023: NOK 105.9 million ), and EBITDA of NOK 7.9 million ( NOK -1.2 million ) following positive operational developments and cost control.",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "For further information, please contact:\n\nDan Schneider\n\nPresident and CEO\n\n<em>Photocure</em> <em>ASA</em>\n\nTel: + 1-609 759-6515\n\nEmail: [email protected]\n\n\n\nErik Dahl\n\nChief Financial Officer\n\nTel: +47 450 55 000\n\nEmail: [email protected]\n\n\n\nDavid Moskowitz\n\nVice President of Investor Relations\n\nTel: +1 202 280 0888\n\nEmail: [email protected]\n\nMedia and IR",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "enquiries:\n\nGeir Bjørlo\n\nCorporate Communications ( Norway )\n\nTel: +47 91540000\n\nEmail: [email protected]\n\nAbout <em>Photocure</em> <em>ASA</em>\n\nPhotocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients.",
"sentiment": -0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (<em>OSE</em>: <em>PHO</em>). For more information, please visit us at www.photocure.com, www.hexvix.com, www.cysview.com\n\nAll trademarks mentioned in this release are protected by law and are registered trademarks of <em>Photocure</em> <em>ASA</em>.",
"sentiment": 0.6682,
"highlighted_in": "main_text"
},
{
"highlight": "This stock exchange announcement was published by Tolv Hillestad, Group Controller, <em>Photocure</em> <em>ASA</em>, on 15 May 2024 at 08:00 CEST .\n\nThis information was brought to you by Cision http://news.cision.com\n\nhttps://news.cision.com/photocure/r/<em>photocure</em>-<em>asa</em>--results-for-the-first-quarter-of-2024,c3981581\n\nThe following files are available for download:",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Photocure</em> <em>ASA</em>: Results for the first quarter of 2024 By Investing.com",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "PHO.OL",
"total_documents": 1,
"sentiment_avg": 0.13478299975395203
}
]
}
Other details
Exchange
- Oslo Stock Exchange
- equity
- Healthcare
- no